Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions

Authors: Asher Chanan‐Khan, János Szebeni, Sándor Sávay, Leonard Liebes, NAILA RAFIQUE, Carl R. Alving, Franco M. Muggia - Annals of Oncology 2003 cited by 469